These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 3914964)

  • 21. [Can we control pertussis better? II. Old and new vaccines against pertussis].
    Gałazka A
    Przegl Epidemiol; 1997; 51(3):285-95. PubMed ID: 9411499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pertussis in 1997].
    Tomaszunas-Błaszczyk J
    Przegl Epidemiol; 1999; 53(1-2):23-32. PubMed ID: 10402846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pertussis--New Zealand 1982/83.
    Begg RC
    N Z Med J; 1984 Jun; 97(758):408-11. PubMed ID: 6589532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
    Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
    Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of routine vaccination with a pertussis toxoid vaccine in Denmark.
    Hviid A; Stellfeld M; Andersen PH; Wohlfahrt J; Melbye M
    Vaccine; 2004 Sep; 22(27-28):3530-4. PubMed ID: 15315832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status of pertussis and pertussis vaccination in Finland.
    Mertsola J; Viljanen MK; Ruuskanen O
    Ann Clin Res; 1982 Dec; 14(5-6):253-9. PubMed ID: 7171232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Studies of effectiveness of vaccination against pertussis during 1997-1998 outbreak in Poland].
    Zieliński A; Czarkowski MP
    Przegl Epidemiol; 2001; 55(1-2):207-15. PubMed ID: 11556082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Time for booster doses against whooping cough for 10-year-old children].
    Carlsson RM; Ekholm L; Gothefors L; Granström M; Trolin I; Tegnell A
    Lakartidningen; 2005 Aug 29-Sep 4; 102(35):2394-8. PubMed ID: 16184889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Characteristics of children with diagnosed pertussis].
    Kardas-Sobantka D; Golebiowska M; Libich M; Stryjewska I
    Przegl Epidemiol; 2000; 54(3-4):357-65. PubMed ID: 11349599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Japanese clinical experiences with acellular pertussis vaccines.
    Kimura M
    Dev Biol Stand; 1991; 73():5-9. PubMed ID: 1778333
    [No Abstract]   [Full Text] [Related]  

  • 32. Pertussis vaccine acceptance rates and incidence of pertussis in forty seven districts (prefectures) in Japan since 1977.
    Kimura M; Kuno-Sakai H; Ozaki K
    Tokai J Exp Clin Med; 1988; 13 Suppl():9-13. PubMed ID: 3273621
    [No Abstract]   [Full Text] [Related]  

  • 33. Hospital-based active surveillance of childhood pertussis in Austria from 1996 to 2003: estimates of incidence and vaccine effectiveness of whole-cell and acellular vaccine.
    Rendi-Wagner P; Kundi M; Mikolasek A; Vécsei A; Frühwirth M; Kollaritsch H
    Vaccine; 2006 Aug; 24(33-34):5960-5. PubMed ID: 16757063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of the emergent vaccination using DTP vaccine to control the outbreak of pertussis].
    Sun D
    Zhonghua Liu Xing Bing Xue Za Zhi; 1990 Dec; 11(6):345-7. PubMed ID: 2276184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Verification of components of acellular pertussis vaccines that have been distributed solely, been in routine use for the last two decades and contributed greatly to control of pertussis in Japan.
    Kuno-Sakai H; Kimura M; Watanabe H
    Biologicals; 2004 Mar; 32(1):29-35. PubMed ID: 15026023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of acellular pertussis vaccine in young infants.
    Aoyama T; Iwata T; Iwai H; Murase Y; Saito T; Akamatsu T
    J Infect Dis; 1993 Feb; 167(2):483-6. PubMed ID: 8421187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Swedish efficacy trial of acellular pertussis vaccines--update and time for reflection.
    Olin P
    Dev Biol Stand; 1991; 73():33-6. PubMed ID: 1778327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outbreak of pertussis in a closed population with a high vaccination rate.
    Shvartzman P; Swartz T; Stopler T; Herman J
    Isr J Med Sci; 1991 Mar; 27(3):137-40. PubMed ID: 2016153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands.
    de Greeff SC; Mooi FR; Schellekens JF; de Melker HE
    Pediatr Infect Dis J; 2008 Mar; 27(3):218-23. PubMed ID: 18277916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotype specificity of vaccine-induced immunity to pertussis.
    Preston NW; Carter EJ
    Commun Dis Rep CDR Rev; 1992 Dec; 2(13):R155-6. PubMed ID: 1285135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.